Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer. Samuel E, Chiang C, Jennens R, Faulkner D, et al. Eur J Cancer 2020;126:104-105.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Samuel E, Chiang C, Jennens R, Faulkner D, et al. Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer. Eur J Cancer 2020;126:104-105.
PMID: 31927211